George L. Sing - Feb 8, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Feb 8, 2024
Transactions value $
-$536,670
Form type
4
Date filed
2/12/2024, 04:02 PM
Previous filing
Jan 4, 2024
Next filing
Feb 26, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $207K +500 +1.9% $413.33 26.8K Feb 8, 2024 Direct
transaction REGN Common Stock Sale -$473K -500 -1.86% $945.00 26.3K Feb 8, 2024 Direct
transaction REGN Common Stock Options Exercise $207K +500 +1.9% $413.33 26.8K Feb 9, 2024 Direct
transaction REGN Common Stock Sale -$478K -500 -1.86% $955.00 26.3K Feb 9, 2024 Direct
holding REGN Common Stock 750 Feb 8, 2024 by Spouse
holding REGN Common Stock 400 Feb 8, 2024 by Spouse/Cust Son
holding REGN Common Stock 1K Feb 8, 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -500 -4.61% $0.00 10.3K Feb 8, 2024 Common Stock 500 $413.33 Direct F1
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -500 -4.84% $0.00 9.84K Feb 9, 2024 Common Stock 500 $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.